psoriasis vulgaris
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who were registered in the TSGP investigation between November 2014 and May 2015, and visited the hospital 4 or more times after the 3-month follow-up 2.Patients who fulfill the criterion 1) in March-June 2016 (as of March 2016, have visited the hospital regularly after the 3-month follow-up and are expected to visit 4 or more times by the end of June) 3.Patients who have used dovobet for more than 1 year 4.Patients who are aged 20 years and have given consent
Exclusion criteria
Exclusion criteria: 1.Patients who are or may be pregnant and those who are breast-feeding 2.Patients judged to be inappropriate as a subject of this study by the investigator physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatments for psoriasis vulgaris. Satisfaction with treatment. | — |
Countries
Japan
Contacts
QOL RD Co.,Ltd. Clinical Research Department CRO Division